BLUEBIRD BIO Forum: Community User: maka

Habt ihr auch das Abfindungsangebot bekommen?

https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-definitive-agreement-be-acquired-carlyle

Was ist hier passiert

Am 12.12. RS

Die am Wochenende publizieren Daten scheinen erstmal gut aufgenommen zu werden

Nachbörslich hat sie wieder ordentlich Federn gelassen

👌🏻

https://www.investing.com/news/swot-analysis/bluebird-bios-swot-analysis-gene-therapy-firm-faces-cash-crunch-amid-launch-93CH-3734838

🚀🚀🚀

Der letzte macht das Licht aus?

Jeden Tag aufs neue allzeittiefs

https://www.fiercepharma.com/pharma/bluebird-making-progress-appears-trail-vertex-patient-starts-sickle-cell-disease

Gibt's News?

Today, bluebird bio announces the first person living with sickle cell has initiated treatment with our sickle cell disease gene therapy in the commercial setting. Andrew Obenshain, chief executive officer, shares his reflection on this milestone: “Seeing people living with sickle cell disease receive gene therapy in the real world is a vision that has fueled bluebird for more than 10 years. This historic moment comes nearly a century after sickle cell disease was the first genetic disorder to be characterized at the molecular level, and almost a decade after bluebird initiated clinical development for our sickle cell gene therapy. We are grateful to the patients, caregivers, researchers, and clinicians whose work made this milestone possible, and look forward to continued partnership with the sickle cell disease community.”